Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression

Kamilla W Miskowiak, Maj Vinberg, Catherine J Harmer, Hannelore Ehrenreich, Lars V Kessing

66 Citationer (Scopus)

Abstract

Current pharmacological treatments for depression have a significant treatment-onset-response delay, an insufficient efficacy for many patients and fail to reverse cognitive dysfunction. Erythropoietin (EPO) has neuroprotective and neurotrophic actions and improves cognitive function in animal models of acute and chronic neurodegenerative conditions and in patients with cognitive decline.
OriginalsprogEngelsk
TidsskriftPsychopharmacology
Vol/bind219
Udgave nummer3
Sider (fra-til)687-98
Antal sider12
ISSN0033-3158
DOI
StatusUdgivet - 2012

Fingeraftryk

Dyk ned i forskningsemnerne om 'Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression'. Sammen danner de et unikt fingeraftryk.

Citationsformater